NASDAQ · MASS
908 Devices Inc.
$12.85-$0.02 (-0.16%)
908 Devices Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
Loading market information…
NASDAQ · LFMD · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
LifeMD, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
LifeMD, Inc.’s next earnings report is currently expected on Nov 9, 2026, with estimated earnings per share of -$0.14. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow LifeMD, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 6, 2025 |
| $0.01+125.0% vs estimate |
| $65.70M+0.36% vs estimate |
| Q4 2024 | Mar 10, 2025 | -$0.02+50.0% vs estimate | $64.25M+7.77% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | -$0.14-16.67% vs estimate | $53.27M-7.69% vs estimate |
|---|
THE ANALYST VIEW
10 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 5 contributors · Median target $7.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$12.85-$0.02 (-0.16%)
908 Devices Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
$9.57+$0.33 (+3.57%)
Sight Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
$9.75+$0.41 (+4.39%)
Senseonics Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.36% below the high.
$2.44+$0.02 (+0.83%)
Cerus Corporation’s quoted price sits in the upper half of its reported 52-week range, 29.68% below the high.
$8.09+$0.23 (+2.93%)
Alpha Teknova, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.66% below the high.
$26.24$0.00 (0.0%)
TruBridge, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.02% below the high.
$32.92+$0.04 (+0.11%)
Sanara MedTech Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.33% below the high.
$2.66-$0.03 (-1.12%)
High Tide Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.02% below the high.
